Tena-Suck ML, Moreno-Reyes I, Rembao D, Vega R, Moreno-Jiménez S, Castillejos-López MJ, Fernández-Plata R, Martínez-Briseño D, Salinas-Lara C

Language: Spanish
References: 25
Page: 361-368
PDF size: 310.15 Kb.

ABSTRACT

Background: Craniopharyngioma is a sellar region benign cyst. It’s frequency ranges from 1.2% to 4.6% of all brain tumors.
Objective: To carry out a clinical pathological correlation of craniopharyngioma among adults and describe the tumor’s biological characteristics.
Methods: We included 115 craniopharyngiomas; 100 were adamantimomatous and 15 were papillary type. Patient’s age range was 15-90 years (mean 52.5 yrs); 54 (47%) were males and 61 (53%) females. The most frequent location was the supraselar region in 49(42.6%) of cases. Total exeresis was performed in 72 patients (62.6%) and partial exeresis in 43 (37.4%).
Results: We noted a recurrence among 50 patients (43%), of which 5/15 were papillary and 45/100 adamantinomatous. The mean patient age for recurrent tumors was 50.46±14.13yrs and 48.65±11.95 for non recurrent tumors. Thirteen patients died (11.3%). We observed a statistical correlation between recurrence, exeresis (p=0.014), and death (p=0.047). Follow-up was longer among females than males and in suprasellar tumor location, papillary type, external epithelium cysts and laxo stellate reticulum.
Conclusions: However a good prognostic factor in craniopharyngiomas was observed in older female patients with complete exeresis, small tumors, external epithelium cysts, edematous stroma, inflammation, and absence of atypical cell and mitosis.

REFERENCES

1. Keihues P, Cavanee K. World Health Organization. Classification of tumors, pathology & genetic, tumours of the nervous system. Geneva: IARC; 2000.

2. Russell DS, Rubisntein JL. Craniopharyngioma and suprasellar epidermoid cyst. En: Russell DS, Rubinstein LJ, editors. Pathology of the tumours of the nervous system. 5th edition. London: Edward Arnold; 1989. pp. 695-702.

3. Beatriz S, Lopez K, Thapar K, Hovath E, and Kovacs K. Sellar neoplasms exclusive of pituitary tumors. En: Russell & Rubinstein‘s Pathology of tumours of nervous System. McLendon RE, Rosenblum MK, Bigner DD (Eds.), Hodder Education, 7a. edición, Londres, UK, 2006; pp. 722-732.

4. Asa SL. Atlas of the tumors pathology. Tumors of the pituitary gland. Third Series, Fascicle 22. Washington DC: Armed Forces Institute of Pathology, 1998, pp. 214-234.

5. Hetelekidis S, Barnes DP, Tao ML, Fischer EG, Schneider I, Scott RM, Tarbell NJ. 20 year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1993;27:189-195.

6. Van Effenterre R, Boch AL. Craneopharyngioma in adults and children; a study of 122 surgical cases. J Neurosurg 2002;97:3-11.

7. Adamson TE, Weistler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngioma. J Neurosurg 1990;73:12-17.

8. Al-Mefty O, Ayoubi S, Kadri PA. The petrosal approach for the total removal of giant retrochiasmatic craniopharyngioma in children. J Neurosurg 2007;106:87-92.

9. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatrics 2008;1:126-130.

10. Shi XE, Wu B, Fan T, Zhou ZQ, Zhang YL. Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg 2008;110:151-159.

11. Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol 2007;31:1020-1028.

12. Grover WD, Rorke LB. Invasive craniopharyngioma, J Neurol Neurosurg Psychiatry 1968;31:580-582.

13. Van Effenterre R, Boch AL. Craniopharyngioma. Ann Endocrinol 2007;68:412-421.

14. Crotty TB, Scheithauer BW, Toung WF jr, Davis DH, Shaw EG, Miller GM, et al. Papillary craniopharyngioma, a clinicopathological study of 48 cases. J Neurosurg 1995;83:206-214.

15. Bikmaz K, Guerrero CA, Dammers R, Krisht AF, Husain MM. Ectopic recurrence of craniopharyngioma, case report. Neurosurgery 2009;64:E382-E383.

16. Yamada Y, Haraoka J, Akimoto J. Ectopic recurrence of craniopharyngioma. Neurol Med Chir 2006;46:598-600.

17. Honegger J, Tatagiba M. Craniopharyngioma surgery. Pituitary 2008;11:361-373.

18. Vinchon M, Dhellemmes P. Craniopharyngiomas in children: recurrence, reoperation and outcome. Childs Nerv Syst 2008;24:211-217.

19. Ragel BT, Bishop FS, Couldwell WT. Recurrent infrasellar clival craniopharyngioma. Acta Neurochir 2007;149:729-730.

20. Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, et al. Craniopharyngioma, a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994;35:1001-1010.

21. Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. Pediatric craniopharyngioma, classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 2007;106:3-12.

22. Baldé NM, Diallo MM, Poirier JY, Sow MS, Brassier G, Lorcy Y. Long-term outcome of the adult onset craniopharyngiomas. Ann Endocrinol 2007;68:186-190.

23. Kawamata T, Kubo O, Hori T. Histological findings at the boundary of craniopharyngioma. Brain Tumor Pathol 2005;22:75-78.

24. Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, et al. Surgery with or without radiation therapy in the management of craniopharyngioma in children and young adults. Int J Radiat Oncol Biol Phys 2004;58:714-720.

25. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-431.